S. Lilly Zheng
Shanghai Medical College of Fudan University(CN)Wenzhou University(CN)Shandong University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Huazhong Agricultural University(CN)National University of Life and Environmental Sciences of Ukraine(UA)National Clinical Research Center for Digestive Diseases(CN)Fudan University Shanghai Cancer Center(CN)Zhejiang Cancer Hospital(CN)Zhongda Hospital Southeast University(CN)V.I.Shumakov Federal Research Center of Transplantology and Artificial Organs(RU)Shanghai Cancer Institute(CN)Blood Center of Zhejiang Province(CN)Zhejiang Shuren University(CN)Guangdong Academy of Medical Sciences(CN)Guangdong Provincial People's Hospital(CN)Second Affiliated Hospital of Zhejiang University(CN)Ministry of Public Health(MG)Pancreas Centre (Canada)(CA)First Affiliated Hospital Zhejiang University(CN)State Key Laboratory of Microbial TechnologyZhejiang University(CN)Shandong University of Science and Technology(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Genetic Associations and Epidemiology, Prostate Cancer Diagnosis and Treatment, Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities, Cancer-related molecular mechanisms research
Most-Cited Works
- → Germline Mutations in HOXB13 and Prostate-Cancer Risk(2012)662 cited
- → Cumulative Association of Five Genetic Variants with Prostate Cancer(2008)632 cited
- → Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk(2002)389 cited
- → Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer(2008)372 cited
- → Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death(2016)337 cited
- → Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma(2012)318 cited